The long-term survival of stage IV gastric cancer patients with conversion therapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The long-term survival of stage IV gastric cancer patients with conversion therapy
Authors
Keywords
Gastric cancer, Conversion therapy, Adjuvant surgery, Chemotherapy, Metastatic gastric cancer
Journal
Gastric Cancer
Volume 21, Issue 2, Pages 315-323
Publisher
Springer Nature
Online
2017-06-14
DOI
10.1007/s10120-017-0738-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Conversion therapy for gastric cancer: who can make conversion as successful as Goromaru?
- (2016) Masanori Terashima Gastric Cancer
- A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002
- (2016) Seiji Ito et al. Gastric Cancer
- Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial
- (2016) Kazumasa Fujitani et al. LANCET ONCOLOGY
- Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer
- (2015) Minoru Fukuchi et al. ANNALS OF SURGICAL ONCOLOGY
- Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer
- (2015) J. Kinoshita et al. EJSO
- Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification
- (2015) Kazuhiro Yoshida et al. Gastric Cancer
- Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer
- (2014) Y. Yamada et al. ANNALS OF ONCOLOGY
- Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis
- (2014) A. Tsuburaya et al. BRITISH JOURNAL OF SURGERY
- HER2 expression in locally advanced gastric cancer with extensive lymph node (bulky N2 or paraaortic) metastasis (JCOG1005-A trial)
- (2014) Tomohiro Matsumoto et al. Gastric Cancer
- Gastric adenocarcinoma with para-aortic lymph node metastasis: a borderline resectable cancer?
- (2014) Yasuhiro Kodera et al. SURGERY TODAY
- Salvage Gastrectomy After Intravenous and Intraperitoneal Paclitaxel (PTX) Administration with Oral S-1 for Peritoneal Dissemination of Advanced Gastric Cancer with Malignant Ascites
- (2013) Joji Kitayama et al. ANNALS OF SURGICAL ONCOLOGY
- Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START)
- (2013) Wasaburo Koizumi et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210)
- (2013) Yoshiaki Iwasaki et al. JOURNAL OF SURGICAL ONCOLOGY
- Management of gastric cancer in Asia: resource-stratified guidelines
- (2013) Lin Shen et al. LANCET ONCOLOGY
- Pilot Feasibility Study of Neoadjuvant Chemoradiotherapy with S-1 in Patients with Locally Advanced Gastric Cancer Featuring Adjacent Tissue Invasion or JGCA Bulky N2 Lymph Node Metastases
- (2012) Tatsushi Inoue et al. ANNALS OF SURGICAL ONCOLOGY
- Outcomes of surgery aiming at curative resection in good responder to induction chemotherapy for gastric cancer with distant metastases
- (2012) Dong-Seok Han et al. JOURNAL OF SURGICAL ONCOLOGY
- Effective palliation and quality of life outcomes in studies of surgery for advanced, non-curative gastric cancer: a systematic review
- (2011) Alyson L. Mahar et al. Gastric Cancer
- New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points
- (2011) Takeshi Sano et al. Gastric Cancer
- Phase II trial of combined treatment consisting of preoperative S-1 plus cisplatin followed by gastrectomy and postoperative S-1 for stage IV gastric cancer
- (2011) Seiji Satoh et al. Gastric Cancer
- Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002)
- (2011) Hiroyuki Narahara et al. Gastric Cancer
- The Roles of Surgical Oncologists in the New Era – Minimally Invasive Surgery for Early Gastric Cancer and Adjuvant Surgery for Metastatic Gastric Cancer
- (2011) Kazuhiro Yoshida et al. PATHOBIOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Preliminary trial of adjuvant surgery for advanced gastric cancer
- (2010) T. SUZUKI et al. Oncology Letters
- The Clavien-Dindo Classification of Surgical Complications
- (2009) Pierre A. Clavien et al. ANNALS OF SURGERY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
- (2008) Wasaburo Koizumi et al. LANCET ONCOLOGY
- D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer
- (2008) Mitsuru Sasako et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search